Andersen Tawil syndrome – a case study
DOI:
https://doi.org/10.12775/JEHS.2021.11.04.005Keywords
Andersen Tawil Syndrome, Andersen, Tawil, ATS, protein KIR 2.1, dilated cardiomyopathyAbstract
The first case of a patient with periodic paralysis of muscles accompanied by ventricular arrhythmias was described in 1963 by Klein and colleagues[1]. In 1971, the team led by E.D. Andersen published a paper on the familial coexistence of neurological disorders and arrhythmias accompanied by dysmorphic features, suggesting a new, unclassified disease syndrome [2]. Another report, this time by the Tawil team, analized 10 cases described up to the time and 4 new diagosed by him, giving the genetic basis for understanding the mechanisms of the disease inheritance [3]. In 2003, the syndrome described by Tawilla was named after Andersen and Tawill (Andersen Tawil Syndrome - ATS).
ATS (syn. long QTc syndrome, type 7, LQTS 7,) is a rare genetic disorder inherited in an autosomal dominant manner. So far around 200 diagnoses of ATS have been made in the world. Mutations in the KCNJ2 gene located on the long arm of chromosome 17, encoding the Kir 2.1 protein, are responsible for the disease subtype 1, which accounts for 60% of the described cases. This protein is a component of the potassium ion channel, and its abnormal structure and function is the cause of repolarization disorders in the cells of the heart and skeletal muscles. However, in 6-20% of patients from families with confirmed presence of KCNJ2 mutations, no clinical symptoms of the syndrome were reported. It proves its differentiated penetration, and the genetic mechanism in the remaining patients remains unknown.
Despite the fact that patients with ATS are a very heterogeneous group in terms of the observed symptoms, this syndrome has a classic triad:
changes in the ECG trace of the T wave and the presence of the U wave (extended duration of the descending arm of the T wave, a characteristic wide U wave and a wide combination of T and U waves - these features distinguish ATS from other long QTc syndromes) and arrhythmias in the form of single multifocal premature ventricular beats, polymorphic, bidirectional ventricular tachycardia, which may be asymptomatic or, more often, cause palpitations. Less common manifestations of arrhythmias are fainting, cardiac arrest and sudden cardiac death[4].
2. periodic muscle strenght impairment (periodic paralysis) occurring most often after a prolonged period of rest or during rest after intense exercise, accompanied by a decrease in the concentration of potassium in the blood serum; in some cases, there is a constant, albeit slight, weakening of muscle strength
3. typical malformations (dysmorphia), most often including short stature, hypertelorism, small mandible, low-set auricles and abnormalities of curvature within the spine.
In patients with an unconfirmed genetic mutation, the diagnosis of ATS requires at least two of the above-mentioned symptoms. However, in some genetically confirmed cases their expression may be very low[5]
Due to the described dysfunctions in the cognitive sphere, mainly in the field of reading skills and mathematical skills, patients should also be covered by psychological care, and due to behavioral changes, in some cases also psychiatric.
References
Klein R., Ganelin R., Marks J.F. et all. Periodic paralysis with cardiac arrythmia. J Pediatr. 1963; 62: 371-385
Andersen E.D., Krasilnikoff P.A., Overvad H. Intermittent muscular weakness, extrasystoles and multiple development al anomalie. A new syndrome? Acta Paediat Scand 1971; 60: 559-564
Tawil R., Ptacek L.J., Paclakis S.G., et all. Andersen’s syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann Neurol. 1994; 35: 326-330
Haruna Y, Kobori A, Makiyama T, Yoshida H, Akao M, Doi T, Tsuji K, Ono S, Nishio Y, Shimizu W, Inoue T, Murakami T, Tsuboi N, Yamanouchi H, Ushinohama H, Nakamura Y, Yoshinaga M, Horigome H, Aizawa Y, Kita T, Horie M. Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome. Hum Mutat. 2007;28:208.
Tristani-Firouzi M, Jensen JL, Donaldson MR, Sansone V, Meola G, Hahn A, Bendahhou S, Kwiecinski H, Fidzianska A, Plaster N, Fu YH, Ptacek LJ, Tawil R. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest. 2002;110:381–8.
Zhang L, Benson DW, Tristani-Firouzi M, Ptacek LJ, Tawil R, Schwartz PJ, George AL, Horie M, Andelfinger G, Snow GL, Fu YH, Ackerman MJ, Vincent GM. Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype. Circulation. 2005;111:2720–6.
Tristani-Firouzi M, Jensen JL, Donaldson MR, et al. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 2002; 110: 381-8.
Smith AH, Fish FA, Kannankeril PJ. Andersen-Tawil syndrome. Indian Pacing Electrophysiol J 2006; 6: 32-43.
Andelfinger G, Tapper AR, Welch RC, et al. KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes. Am J Hum Genet 2002; 71: 663-68.
Schoonderwoerd BA, Wiesfeld AC, Wilde AA, van den Heuvel F, Van Tintelen JP, van den Berg MP, Van Veldhuisen DJ, Van Gelder IC. A family with Andersen-Tawil syndrome and dilated cardiomyopathy. Heart Rhythm. 2006;3:1346–50.
Donaldson MR, Jensen JL, Tristani-Firouzi M, Tawil R, Bendahhou S, Suarez WA, Cobo AM, Poza JJ, Behr E, Wagstaff J, Szepetowski P, Pereira S, Mozaffar T, Escolar DM, Fu YH, Ptácek LJ. PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome. Neurology. 2003;60:1811–6.
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 572
Number of citations: 0